Global Apheresis Market to Surge from US$ 3,248.3 Million in 2023 to US$ 6,882.1 Million by 2032, Driven by Robust 8.7% CAGR | Astute Analytica

The global 𝐚𝐩𝐡𝐞𝐫𝐞𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭, a pivotal segment within the healthcare industry, is experiencing significant growth, with a valuation of 𝐔𝐒$ 𝟑,𝟐𝟒𝟖.𝟑 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑. According to new projections, the market is set to achieve a remarkable valuation of 𝐔𝐒$ 𝟔,𝟖𝟖𝟐.𝟏 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐. This growth represents a robust compound annual growth rate (𝐂𝐀𝐆𝐑) 𝐨𝐟 𝟖.𝟕% during the forecast period from 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟐.

𝐓𝐡𝐞 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞- https://www.astuteanalytica.com/request-sample/apheresis-market

Apheresis, a medical technology used to separate and remove specific components from blood, has seen increased adoption due to its critical role in therapeutic treatments and advanced research. The expanding applications of apheresis, including its use in treating autoimmune disorders, cancer, and blood disorders, are key drivers of this market surge. Additionally, technological advancements in apheresis equipment and increasing awareness about the benefits of therapeutic apheresis contribute to the market's growth.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬

𝐃𝐫𝐢𝐯𝐞𝐫: 𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐃𝐞𝐦𝐚𝐧𝐝 𝐟𝐨𝐫 𝐏𝐥𝐚𝐬𝐦𝐚-𝐝𝐞𝐫𝐢𝐯𝐞𝐝 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐬

The growing demand for plasma-derived products is a key driver for the global apheresis market. Plasma-derived products are widely used in the treatment of various medical conditions such as immune deficiencies, bleeding disorders, and certain types of cancers. The global market for plasma-derived products was valued at around $26.2 billion in 2023 and is projected to reach $41.5 billion by 2032. As of 2023, the plasma protein therapeutics market alone is valued at about $24 billion, indicating a strong demand for plasma-derived products.

The primary factor behind this growth is the rising prevalence of conditions that require plasma-derived products. According to the World Federation of Hemophilia, there were approximately 200,000 people with hemophilia worldwide in 2022, and the number is expected to increase due to better diagnosis and population growth. The increasing use of albumin in surgery and emergency medicine is another contributor to the rising demand. This growing demand is driving the need for plasma collection, which is primarily done through apheresis. Plasma apheresis is preferred over whole blood donations for plasma collection as it allows for more frequent donations and provides higher-quality plasma.

𝐅𝐨𝐫 𝐟𝐮𝐫𝐭𝐡𝐞𝐫 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐚𝐩𝐡𝐞𝐫𝐞𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐧𝐝 𝐝𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐢𝐧𝐭𝐨 𝐦𝐚𝐫𝐤𝐞𝐭 𝐭𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐢𝐨𝐧𝐬, 𝐩𝐥𝐞𝐚𝐬𝐞 𝐜𝐨𝐧𝐭𝐚𝐜𝐭: - https://www.astuteanalytica.com/industry-report/apheresis-market

The market's expansion is also supported by the rising prevalence of chronic diseases and the growing demand for effective treatment options. As healthcare providers and researchers continue to seek innovative solutions for complex medical conditions, the apheresis market is well-positioned for sustained growth.

Industry leaders are optimistic about the future of the apheresis market, with ongoing research and development efforts expected to introduce new products and enhance existing technologies. The convergence of medical advancements and a growing patient population ensures that the apheresis market will remain a dynamic and evolving sector in the global healthcare landscape.

𝐓𝐨𝐩 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐀𝐩𝐡𝐞𝐫𝐞𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭

• Asahi Kasei Medical Co. Ltd.
• B. Braun Melsungen AG
• Baxter International Inc.
• Cerus Corporation
• Charles River Laboratories International, Inc.
• Haemonetics Corporation
• Kaneka Corporation
• Kawasumi Laboratories Inc
• Nikkiso Co., Ltd.
• Terumo BCT, Inc
• Fresenius Kabi
• Other Prominent Players

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭

• Apheresis Disposables
• Apheresis Devices

𝐁𝐲 𝐓𝐲𝐩𝐞

• Plasmapheresis
• Plateletpheresis
• Erythrocytapheresis
• Leukapheresis
• Photopheresis
• Other

𝐁𝐲 𝐏𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐞

• Automated blood collection (Donor Apheresis)
• Therapeutic Apheresis

𝐁𝐲 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲

• Centrifugation
• Membrane Separation
• Selective Adsorption

𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫

• Hospital
• Blood Collection Center

𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧

• North America
o The U.S.
o Canada
o Mexico

• 𝐄𝐮𝐫𝐨𝐩𝐞

o Western Europe
 The UK
 Germany
 France
 Italy
 Spain
 Rest of Western Europe

𝐨 𝐄𝐚𝐬𝐭𝐞𝐫𝐧 𝐄𝐮𝐫𝐨𝐩𝐞

 Poland
 Russia
 Rest of Eastern Europe

• 𝐀𝐬𝐢𝐚 𝐏𝐚𝐜𝐢𝐟𝐢𝐜

o China
o India
o Japan
o Australia & New Zealand
o ASEAN
o Rest of Asia Pacific

• 𝐌𝐢𝐝𝐝𝐥𝐞 𝐄𝐚𝐬𝐭 & 𝐀𝐟𝐫𝐢𝐜𝐚 (𝐌𝐄𝐀)

o UAE
o Saudi Arabia
o South Africa
o Rest of MEA

• 𝐒𝐨𝐮𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚

o Argentina
o Brazil
o Rest of South America

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭@- https://www.astuteanalytica.com/request-sample/apheresis-market

𝐀𝐛𝐨𝐮𝐭 𝐀𝐬𝐭𝐮𝐭𝐞 𝐀𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐚:

Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.

They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyse for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.

𝐆𝐞𝐭 𝐢𝐧 𝐭𝐨𝐮𝐜𝐡 𝐰𝐢𝐭𝐡 𝐮𝐬

𝐏𝐡𝐨𝐧𝐞 𝐧𝐮𝐦𝐛𝐞𝐫: +18884296757
𝐄𝐦𝐚𝐢𝐥: sales@astuteanalytica.com
𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://www.astuteanalytica.com/
LinkedIn | Twitter | YouTube | Facebook

This release was published on openPR.